|
Originally published In Press as doi:10.1074/jbc.M202941200 on April 26, 2002
J. Biol. Chem., Vol. 277, Issue 27, 24225-24231, July 5, 2002
A Novel Pathway for Nickel-induced Interleukin-8
Expression*
Aaron
Barchowsky ,
Nicole V.
Soucy,
Kimberley A.
O'Hara,
John
Hwa,
Trisha L.
Noreault, and
Angeline S.
Andrew
From the Department of Pharmacology and Toxicology, Dartmouth
Medical School, Hanover, New Hampshire 03755
Received for publication, March 27, 2002
 |
ABSTRACT |
Inhalation of particulate nickel subsulfide
(Ni3S2) causes chronic active
inflammation and fibrosis of the lungs. However, the mechanisms for
these effects are not well understood. Therefore, cell culture
experiments with BEAS-2B human airway epithelial cells were conducted
to test the hypothesis that exposure to non-cytotoxic levels of
Ni3S2 induces expression of inflammatory
cytokines such as interleukin-8 (IL-8). Exposure to
Ni3S2 for 48 h was required to
significantly increase IL-8 protein levels. Transcriptional stimulation
of IL-8 mRNA levels preceded the increase in protein. Transient
exposure to soluble nickel sulfate failed to increase IL-8 mRNA.
Transfection with truncated IL-8 promoter constructs linked to the
luciferase gene demonstrated that nickel-induced IL-8 transcription
required 272 bp of the promoter relative to the transcriptional start
site. A 133-bp construct, containing cytokine and hypoxia-sensitive
AP-1, NF-IL6, and NF- B sites, was insufficient for induction by
nickel. Transfection with a dominant negative AP-1 construct or
mutation of the AP-1, GATA, or C/EBP sites in the 272-bp IL-8
promoter construct blocked induction by nickel. Inhibiting ERK,
phosphatidylinositol 3-kinase, but not p38 kinase,
diacylglycerol kinase, or hypoxia-inducible factor-1 , attenuated
nickel induction of IL-8. These studies indicate that nickel induced
IL-8 transcription through a novel pathway that requires both AP-1 and
non-traditional transcription factors.
 |
INTRODUCTION |
Environmental exposure to inhaled nickel particles has been linked
to increased mortality in the United States (1), and inhalation is the
primary route of occupational exposure to nickel compounds (2). In the
lower airways, nickel exposure is associated with immunological
sensitization, epithelial dysplasia, asthma, lung cancer, and fibrosis
(2). At the cellular level, nickel stimulates signaling cascades in
airway epithelium that increase expression of the profibrotic
gene, plasminogen activator inhibitor-1, and genes involved in hypoxic
responses (3-5). This stimulation requires stabilization of
hypoxia-inducible factor
(HIF)1 and AP-1
transcriptional activity (3, 4). These genes may contribute to the
fibrotic process and may be common to the variety of pulmonary diseases
elicited by nickel. In addition, HIF-independent pathways for
nickel-induced transcription are not well described and could
contribute to pleiotropic profibrotic and inflammatory effects observed
in nickel-related lung diseases.
The CXC chemokine interleukin 8 (IL-8) is markedly
up-regulated in pulmonary fibrosis (6-8) and has been implicated in
promoting the growth of lung tumors (9, 10). IL-8 attracts and
activates neutrophils, induces transendothelial migration of
neutrophils, modulates chemotaxis for T-lymphocytes, promotes
angiogenesis, and induces contraction of airway smooth muscle cells
(10, 11). IL-8 mRNA levels were induced in human oral carcinoma and
umbilical vein cells following nickel chloride treatment (12, 13).
Although this suggests that IL-8 expression is sensitive to nickel
exposure, enhanced IL-8 mRNA and protein levels were not detected
in human airway cells exposed to soluble nickel sulfate for 2 h
(14) or dermal cells treated with nickel chloride (13). In addition to
potential cell-type-specific responses to nickel, different nickel
species vary greatly in their kinetics and toxicity (2, 15). The lung
rapidly clears water-soluble nickel salts, but insoluble particulate
forms of nickel can be retained with biological half-lives of up to 3 years (2). Particulate Ni3S2 is one of the most
toxic nickel species with respect to fibrosis and carcinogenesis (15),
yet little is known of its effects on cytokine release.
The IL-8 promoter is found between 1481 and +44 bp of the
transcriptional start site and contains multiple potential regulatory transcription factor binding sites, including glucocorticoids receptor, AP-1, AP-3, C/EBP, octamer motif binding proteins, NF-IL6, and NF- B (11, 16, 17). Cytokine and inflammatory mediators, such as
TNF, IL-1, or endotoxin, require a minimal promoter region of 130 bp,
which contains essential AP-1, NF-IL6, and NF- B sites, to fully
stimulate transcription (16). Glucocorticoids and octamer binding proteins suppress IL-8 by either binding to their own DNA cis
elements or preventing the binding of NF- B (18, 19). The portions of
the IL-8 promoter required for induction by nickel have not been
previously investigated.
Ni3S2, in contrast to soluble nickel, could be
retained in lung cells for a sufficient time to exacerbate the
development of pulmonary inflammation and fibrosis in exposed
individuals (15). The current experiments were designed to examine the
time course for IL-8 expression by human airway epithelial cells
exposed to Ni3S2, and to determine whether this
expression required retention of the particles by the cells. The
results indicate that Ni3S2 causes prolonged
transcriptional activation of the IL-8 gene by stimulating cell
signaling cascades. In contrast, short exposures to soluble nickel do
not induce IL-8 expression. Activation of the IL-8 gene by nickel is
unique in that it does not require elements in the proximal promoter
that are stimulated by other inflammatory mediators.
 |
MATERIALS AND METHODS |
Cells--
Human bronchial epithelial cells (Beas-2B, ATCC,
Rockville, MD) were grown to post-confluence in 6- or 12-well plates
(Corning Costar, Corning, NY) on 1 mg of fibronectin, 0.33 mg of
Vitrogen 100 (Collaborative Research), and 0.1 mg of BSA in 100 ml of
LHC-8 medium (Biofluids), as previously described (3-5). The cultures were maintained in LHC-9 medium (Biofluids Inc., Rockville, MD) at
37 °C under an atmosphere of 5% CO2/95% air.
Nickel--
Respirable size particulate nickel was prepared by
applying Ni3S2 particles (Aldrich, Milwaukee,
WI) to a water column and allowing the larger particles to settle out.
Particle size was measured during settling using a particle counter
(Coulter Corp., Miami, FL). Particles of less than 2.5 µm in diameter
were decanted, concentrated by centrifugation, and sterilized by baking
at 200 °C for 18 h. This preparation gives the same
quantitative and qualitative responses as a standard preparation of
nickel subsulfide obtained from the Nickel Producers Environmental
Research Association (a kind gift from Dr. Andrea Oller). Nickel(II)
sulfate hexahydrate (Aldrich, Milwaukee, WI) was used to prepare
soluble nickel solutions.
Treatments--
Previous studies demonstrated by clonogenic
survival assays that addition of 2.34 µg of
Ni3S2/cm2 of nickel subsulfide were
not toxic to this cell model (5). This amount of
Ni3S2 is roughly equivalent to 90 µM soluble NiSO4. However, direct comparisons
of concentration are not possible due to the inability of
Ni3S2 particles to remain in suspension above
the cells. Tumor necrosis factor- (TNF- ) (10 ng/ml) was used as a
positive control to induce IL-8 expression. Kinase inhibitors (Calbiochem, La Jolla, CA) and antioxidants (Sigma Chemical Co., St.
Louis, MO) were added 30 min prior to adding
Ni3S2.
Protein Levels--
The effect of nickel on secreted IL-8
protein levels was determined using the Quantikine IL-8 Immunoassay
(R&D Biosystems, Minneapolis, MN). Briefly, conditioned medium was
removed from treated cells and centrifuged for 10 min at 2000 rpm to
remove insoluble debris. Protease inhibitors were added, and medium was incubated at 25 °C for 1 h in microtiter wells pre-coated with antibodies specific to IL-8. Western analysis for HIF-1 protein levels was performed using a polyclonal antibody to HIF-1
(Transduction Laboratories, Lexington, KY), essentially as described
previously (3). Immunoreactive bands were detected using horseradish
peroxidase-linked secondary antibody and enhanced chemiluminescence
(PerkinElmer Life Sciences, Boston, MA).
mRNA Levels--
Total cellular RNA was harvested using
TRIzol reagent (Invitrogen, Gaithersburg, MD) according to the
manufacturer's instructions. Reverse transcription-polymerase chain
reaction (RT-PCR) was performed with 0.5 µg of the resulting RNA, as
described previously (5, 20, 21). Specific primers for IL-8 (forward
5'-atgacttccaagctggccgtggct; reverse 5'-tctcagccctcttcaaaaacttctc) and
-actin (forward 5'-gggacctgaccgactactc-3'; reverse
5'-gggcgatgatcttgatcttc-3) were synthesized in the Molecular Biology
Core at Dartmouth. PCR products were either visualized in agarose gels
stained with ethidium bromide or quantified using the double-strand DNA
fluorescent dye Picogreen (Molecular Probes Inc., Eugene, OR) at 430-nm
emission/525-nm absorption. Densitometry was performed on ethidium
bromide-stained gels using IMAGE (National Institutes of Health). IL-8
mRNA expression was normalized to the housekeeping gene -actin
by determining the ratio of the IL-8 to -actin band density or
Picogreen fluorescence.
Transient Transfection--
Seventy percent confluent cells were
transfected with IL-8 promoter constructs, normal and dominant-negative
c-Jun expression plasmids, and enhanced green fluorescence protein
(EGFP) using LipofectAMINE Plus reagent (Invitrogen, Gaithersburg, MD),
as previously described (3, 4). The 1481, 272, 161, or 133 IL-8
promoter constructs linked to luciferase, described previously (11,
22), were a kind gift from Dr. Naofumi Mukaida (Kanazawa University,
Japan). The following site-directed mutants of the 272-luc IL-8
promoter plasmid were prepared by PCR: AP-1 (bp 126 to 120) from
TGACTCA to TatCTCA; GATA (bp 248 to 245) from GATA to GgTA; and
C/EBP (bp 246 to 233) from TAATTCACCAAATT to TAATTCtCtAAAaa. Empty
cytomegalovirus, c-Jun, and TAM67 plasmids were obtained from Dr.
Michael Birrer (National Institutes of Health, Rockville, MD) and
EGFP-N2 plasmid was from CLONTECH (Palo Alto, CA).
Transfection efficiency in each well was assessed by measuring EGFP
fluorescence using a fluorescent plate reader (PE Biosystems (Foster
City, CA), excitation of 485 nm, emission of 508 nm). Transfection
efficiency of BEAS-2B cells was estimated to be ~20-30%.
Luciferase Assay--
Cells were harvested in 80 µl of lysis
buffer (25 mM glycylglycine, 4 mM EGTA, 15 mM MgSO4, 1% Triton X-100, 1 mM
dithiothreitol). The lysates were then centrifuged at 13,000 × g at 4 °C for 5 min. Luciferase activity was determined
using 50 µl of supernatant and 150 µl of fresh assay buffer (25 mM glycylglycine, 15 mM potassium phosphate, 15 mM MgSO4, 4 mM EDTA, 2 mM ATP, 1 mM dithiothreitol) in a Dynatech
Microlite ML 2250 luminometer by injecting 50 µl of 400 µM luciferin.
Antisense Oligonucleotides--
HIF-1 phosphorothioate
antisense and sense oligonucleotides were synthesized in the
Molecular Biology Core at Dartmouth according to sequences published by
Caniggia et al. (23). Cells were incubated for 24 h
with 10 µM sense or antisense oligonucleotides prior to
nickel treatment. Nickel-induced HIF protein levels were suppressed for
greater than 56 h after a single dose of antisense (3).
Statistics--
Statistical analysis was performed on data
pooled from duplicate or triplicate determinations in two to three
separate experiments to yield a total n = 6. Significant differences between treatment groups and controls were
determined using one-way analysis of variance. The means of groups were
compared using the Newman-Keuls post-hoc test. All statistics were
performed using GraphPad Prism, version 3.0 (GraphPad Software, San
Diego, CA). Data are presented as means ± S.D. or as percentage
of control.
 |
RESULTS |
Nickel Stimulates Prolonged IL-8 Protein Release--
The time
course for IL-8 release from untreated BEAS-2B cells was compared with
cells treated with Ni3S2 to determine whether the metal can induce an inflammatory response in airway epithelial cells. Secreted protein was measured by enzyme-linked immunosorbent assay at 24-h intervals following addition of
Ni3S2. As shown in Fig.
1, more than 24 h of nickel exposure
was required before significant increases in IL-8 expression occurred.
These data suggest that particulate nickel stimulates a latent, but
prolonged inflammatory phenotypic change in the BEAS-2B cells.

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 1.
Time course of nickel induced IL-8
protein. Confluent cells were treated with 2.34 µg of
Ni/cm2 nickel subsulfide for 24 or 48 h. The medium
was then collected to measure IL-8 protein levels by enzyme-linked
immunosorbent assay. The data are presented as the mean ± S.D. of
six different wells of cells and are representative of data from three
separate experiments. ***, significant difference from control
(p < 0.001).
|
|
Phenotypic Change in Response to Nickel Occurs at the Level of
Transcription--
Previous reports indicate that nickel induces a
profibrotic phenotype by stimulating transcription of specific genes
(5). To determine whether the observed increases in IL-8 protein were also due to induction of mRNA levels, total RNA was isolated from control cells or cells exposed to nickel subsulfide for up to 48 h. The data in Fig. 2 demonstrate that
nickel stimulates a progressive increase in IL-8 mRNA levels, which
was significantly greater than control by 24 h. These levels
continued to rise between 24 and 48 h and were consistent with the
time course for nickel stimulation of IL-8 protein.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 2.
Time course of nickel-induced IL-8
mRNA. A, cells were incubated for the indicated
times in normal LHC-9 medium or medium containing either 2.34 µg of
Ni/cm2 nickel subsulfide or 20 ng/ml PMA. At the end of the
exposure period, total RNA was extracted and IL-8 and -actin
mRNA levels were amplified by RT-PCR. Ethidium bromide staining was
used to detect PCR products. B, the mean ± S.D. of
the ratio of IL-8 product relative to -actin product band
density was compared with controls. The data represent RNA
collected from separate cultures and are representative of at least six
replicates. ***, significant difference from IL-8 mRNA
levels in non-treated cells (p < 0.001).
|
|
IL-8 can be regulated at both the transcriptional and
post-transcriptional level depending on the cell type and inducing
agent used (16, 17). To determine the effect of nickel IL-8 message stability, cells were exposed to nickel or PMA (10 nM) for
24 h prior to the addition of the transcriptional blocker,
actinomycin D (5 µg/ml). Total RNA was isolated over a 7-h period
following actinomycin D addition to determine the rate of message
degradation. There was no significant difference in the rate of IL-8
mRNA degradation (Fig. 3) indicating
that the increased mRNA levels observed in Fig. 2 were not due to
increased message stability.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Nickel does not affect IL-8 mRNA
stability. Cells were incubated for 24 h in normal LHC-9
medium or medium containing either 2.34 µg of Ni/cm2
nickel subsulfide or 20 ng/ml PMA. Actinomycin D was then added to all
cultures, and total RNA was collected after 2.5, 5, or 7 h. IL-8
and -actin mRNA were amplified by RT-PCR, and products were
quantified by Picogreen fluorescence staining. The data
represent RNA collected from at least six separate cultures and
presented as mean ± S.D. of Picogreen fluorescence.
|
|
Transcriptional Activation by Ni3S2
Requires a Unique Region of the IL-8 Promoter--
To determine
whether nickel induces transcription of IL-8, BEAS-2B cells were
transiently transfected with full-length or truncated portions of the
IL-8 gene promoter linked to a luciferase reporter. The data in Fig.
4A were consistent with transcriptional activation of the promoter within 48 h of exposing the cells to Ni3S2. The proximal 272 bp contained the
minimal nickel-responsive region of the promoter that provided maximal
stimulation of luciferase activity. This 272 bp construct was more
responsive than the full-length construct, consistent with loss of
potential repressive elements, as previously reported for cytokine
induction of the promoter (11, 16, 17). The construct containing 161
bp also responded to Ni3S2 with a significant
increase in luciferase expression. Truncation by another 28-bp
eliminated significant responses. These results differ greatly from
reports defining the 133 bp construct as the minimal promoter for
cytokine-induced IL-8 expression (11, 16, 17). The data in Fig.
4B demonstrated that the time course for nickel-stimulated
expression of the 272 bp construct was consistent with the time
course for increased endogenous IL-8 mRNA. This suggested that
nickel stimulated the gene at the level of transcription. It is also
important to note that the luciferase activity was progressively
increased following exposure to Ni3S2. This
contrasts with induction by TNF, which required only the 133-bp
portion of the 272 construct (11, 16) and declined after 24 h.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
The 272 region of the IL-8 promoter is
nickel-responsive. A, cells were transiently
co-transfected with plasmids expressing the indicated IL-8 promoter
constructs and EGFP. After 24-h equilibration, cells were left
untreated, exposed for 48 h to either 2.34 µg of
Ni/cm2 nickel subsulfide or 10 ng/ml TNF ( 1481 only).
B, cells were co-transfected with constructs expressing the
272 IL-8 promoter and EGFP. After 24-h equilibration, cells
were left untreated then exposed to either
Ni3S2 or TNF for 16, 24, or 48 h.
Following the exposures, expressed luciferase activities were measured.
The data are presented as mean ± S.D. ratio of relative light
units (RLU) normalized to EGFP fluorescence. **, significant
differences from expression of an empty luciferase construct for
p < 0.01, or *** for p < 0.001 (n = 6).
|
|
Induction of IL-8 by Nickel Requires Unique Cis Elements in the
Proximal Promoter--
PCR site-directed mutagenesis of the 272 IL-8
promoter construct was performed to determine which unique cis elements
were required for induction by nickel. Of several putative cis
elements, the adjacent GATA and C/EBP sites at 248 to 245 and 246
to 233, respectively, appeared to be the most relevant sites to lung
inflammation and pathophysiology. Mutation of either of these sites
abolished induction of luciferase activity by nickel but not by TNF
(Fig. 5). Disrupting the C/EBP site
enhanced control and TNF-induced activity indicating that this site may
be somewhat repressive. As discussed below, mutating the AP-1 site at
126 to 120 bp reduced both basal and nickel-induced activity
indicating that cooperativity between proteins binding at this site and
the proximal elements may be needed for full activation of the promoter by nickel.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Nickel requires C/EBP, GATA, and AP-1 cis
elements to induce the IL-8 promoter. The 272 IL-8 promoter
construct was mutated, as described under the "Materials and
Methods," to disrupt C/EBP, GATA, or AP-1 cis elements. Cells were
transfected and treated as in Fig. 4, and luciferase activity was
compared after 48 h of stimulation with nickel or TNF. The data
are presented as mean ± S.D. ratio of relative light units (RLU)
normalized to EGFP fluorescence (n = 3).
|
|
Induction of IL-8 by Ni3S2 Requires Uptake
into the Cells--
Ni3S2 is reported to be
more toxic to the lung due to its uptake into the cells and increased
persistence relative to soluble forms of nickel (2, 15). To demonstrate
that uptake and sustained exposure to Ni3S2
were required for inducing transcription, the effects of short
exposures to Ni3S2 and soluble nickel sulfate on HIF-1 protein and IL-8 mRNA levels were compared. In this paradigm, cells were treated with either form of the metal for 30 min
before the cultures were rinsed and the medium was replaced. Despite
repeated rinsing, microscopic examination demonstrated that
Ni3S2 particles remained associated with the
cells (data not shown). After a 24-h incubation period, total protein
was collected for Western analysis of HIF-1 protein levels and total RNA was collected to measure IL-8 mRNA levels. As seen in Fig. 6A, short term exposure to
Ni3S2 but not nickel sulfate effectively increased HIF-1 protein levels, relative to control. Short term Ni3S2, but not NiSO4, also
increased IL-8 mRNA levels (Fig. 6B). Continuous
exposure of the cells to either form of nickel over the 24-h period
increased IL-8 mRNA levels; although NiSO4 was less
effective (Fig. 6B). These data indicated that prolonged exposure to nickel or slow dissolution of the particles was required for full induction of IL-8.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 6.
Differential effects of soluble and
particulate nickel. A, cells were exposed to either
soluble NiSO4 (90 µM) or particulate
Ni3S2 (2.34 µg Ni/cm2) for 30 min. The cultures were then rinsed and incubated in complete LHC-9
medium for 24 h. Total cellular protein was collected, and Western
analysis was performed with antibody specific for HIF-1 .
B, cells were treated transiently as in A or
continuously for 24 h with either soluble or particulate nickel.
At the end of the 24-h induction period, total RNA was collected and
IL-8 and -actin mRNA levels were determined by RT-PCR.
|
|
IL-8 Induction by Nickel Is Independent of a Hypoxia-like
Response--
Nickel mimics hypoxia to induce profibrotic changes in
BEAS-2B cell PAI-1 expression (3, 5). Hypoxia is capable of inducing IL-8 levels, although this induction required activation of the 133-bp region of the IL-8 promoter (24). Nickel-induced HIF-1 levels and PAI-1 expression are attenuated by inhibiting diacylglycerol kinase (3). Therefore, the effect of the diacylglycerol kinase inhibitor, R-59949, on nickel-induced IL-8 expression was examine to
establish whether induction of PAI-1 and IL-8 share similar HIF-dependent pathways. Under conditions where
nickel-induced HIF protein stabilization was completely blocked (Fig.
7A), R-59949 had little or no
effect on nickel-induced IL-8 expression (Fig. 7B). The HIF
independence of transcriptional activation of IL-8 by nickel was
further demonstrated by the experiments presented in Fig. 7C
where luciferase activity was compared in cells transfected with the
272-luciferase construct and then stimulated with nickel in the
absence or presence of a HIF-1 antisense oligonucleotide. This
antisense sequence is highly effective in preventing nickel from
inducing PAI-1 expression (3). However, neither the antisense nor the
sense control affected luciferase activity in nickel-treated cells
(Fig. 7C). These data confirm that IL-8 expression in
nickel-exposed cells is independent of the hypoxia response, despite
the fact that nickel is capable of mimicking hypoxia by increasing
HIF-1 stability.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 7.
Lack of a role for HIF-1
in induction of IL-8 by nickel. A, duplicate
wells of cells were treated for 24 h with 1.17 µg of
Ni3S2/cm2 in the presence or
absence of 20 µM R-59949. The inhibitor was added 30 min
prior to the nickel. Total cellular protein was collected for Western
HIF-1 protein levels. B, cells were treated with 10 or 20 µM R-59949 for 30 min and then exposed to 1.17 µg of
Ni3S2/cm2 or 90 µM
NiSO4 nickel for an additional 24 h. Total RNA was
collected, and IL-8 and -actin mRNA levels were determined by
RT-PCR. C, cells were co-transfected with the 272-bp IL-8
luciferase construct and the EGFP plasmid for 3 h. LHC-9 medium or
LHC-9 medium containing 10 µM of either HIF-1 sense or
antisense was then added for 24 h. Ni3S2
was then added to the indicated cultures, and all cells were harvested
24 h later for determination of luciferase activity. The data were
presented as mean ± S.D. of the relative light units measured
normalized to EGFP fluorescence. *, significant differences from the
relevant non-nickel-treated control for p < 0.01 (n = 6).
|
|
AP-1 Is Necessary but Not Sufficient for Induction of IL-8 by
Nickel--
In certain cell types, including pulmonary epithelial cell
lines, AP-1 is essential for induction of the IL-8 promoter stimulated by IL-1, TNF- , and human T-cell lymphotrophic virus 1 (11, 16, 22).
Nickel-induced transcription of PAI-1 in BEAS-2B cells also requires
AP-1 activity (4), and the data in Fig. 5 indicate that the AP-1 site
is necessary for stimulation of the IL-8 promoter by nickel. Therefore,
a dominant negative AP-1 construct, TAM67, was used to test the
hypothesis that AP-1 is required for transcriptional activation of IL-8
by nickel. RT-PCR for IL-8 mRNA from cells transfected with the
TAM67 construct with and without nickel treatment indicated that some
basal AP-1 activity is necessary for the induction of IL-8 by nickel
(Fig. 8). Overexpression of c-Jun did not
induce IL-8 mRNA (Fig. 8). These data and the data in Figs.
4A and 5 indicate that the AP-1 site at 126 to 120
bp of the promoter is necessary but not sufficient for induction
of IL-8 by nickel.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 8.
AP-1 is necessary for induction of IL-8 by
nickel. BEAS-2B cells were sham-transfected or transfected with 1 µg/well cytomegalovirus vector, TAM67, or c-Jun plasmid. After
a 24-h equilibration, cells were left untreated then exposed to 2.34 µg of Ni/cm2 nickel subsulfide for an additional 24 h. Total RNA was harvested, and RT-PCR was performed using primers to
IL-8 or -actin mRNA. Bands of PCR products in 2% agarose gels
were detected by ethidium bromide staining and UV
transillumination.
|
|
Nickel Stimulates Kinase Signaling Cascades to Induce IL-8
Transcription--
Nickel-induced transcription of PAI-1 is dependent
on the activation of upstream signaling cascades (3). The role of these pathways in mediating nickel stimulation of IL-8 is unknown. Therefore, cells were pre-treated with specific inhibitors of the ERK (U0126), PI3K (wortmannin), p38 MAPK (SB20358), or diacylglycerol kinase (R-59949) for 30 min prior to a 24-h exposure to
Ni3S2. Inhibition of ERK or PI3K significantly
attenuated but did not eliminate IL-8 induction by nickel (Fig.
9). However, consistent with previous observations for PAI-1 induction (3), there was no effect of inhibiting
p38 kinase on nickel-stimulated IL-8 expression (Fig. 9).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 9.
Effect of kinase inhibitors on induction of
IL-8 by nickel. A, groups of cells were left untreated
or were pre-treated for 90 min with 1 µM wortmannin or 30 min with 20 µM SB203580, 10 µM U0126 and
then incubated in the presence or absence of
Ni3S2 (2.34 µg of Ni/cm2) for
24 h. At the end of the exposure period, total RNA was isolated,
and IL-8 and -actin mRNA levels were determined by RT-PCR. The
data are presented as images of UV-transilluminated, ethidium
bromide-stained product bands in 2% agarose gels.
|
|
 |
DISCUSSION |
The role of IL-8 in inflammatory responses to inhaled toxicants
and lung injury has been extensively studied. In contrast, much less is
known of the cellular and molecular events that regulate IL-8
expression induced by specific toxicants. Particulate nickel represents
an environmentally and occupationally important lung toxicant that
promotes inflammation, airway cell dysplasia, and fibrosis (2).
However, as with all metals, nickel is a pleiotropic cell stimulant
that can affect multiple signaling pathways to alter cell phenotype.
The data presented above indicate that non-toxic exposure to
particulate nickel induces prolonged expression of IL-8 with latent
increases in protein release. This prolonged time course contrasts with
the more rapid nickel-induced effects on fibrinolytic activity and
HIF-dependent expression of PAI-1 and vascular endothelial
cell growth factor seen in this same airway cell model (3-5). It also
contrasts with more rapid IL-8 induction caused by short exposure to
high concentrations of other metals, such as vanadium, chromium, and
zinc (14, 25). However, the data suggest that the uptake and durability
of Ni3S2 contribute to its ability to activate
specific signaling cascades that culminate in increased transcription
of IL-8 mRNA. Addition of a chronic inflammatory state, as
indicated by prolonged increases in IL-8 expression, could compound the
pathophysiological responses of the airways to particulate nickel exposures.
IL-8 induction and its recruitment of inflammatory cells into the lung
may play an important role in disease development. Along with other
cytokines, IL-8 may be responsible for the chronic inflammation that is
characteristic of pulmonary fibrosis. The fact that IL-8 is not induced
by nickel until 24 or 48 h following the onset of exposure may
indicate that other events mediate the pathogenesis of nickel-induced
pulmonary fibrosis, such as inhibition of the fibrinolytic cascade (5).
The prolonged time course may be explained by the need for dissolution
of the particles to accumulate the active Ni2+ that reacts
with proteins and DNA (15, 26). Retention of nickel subsulfide
particles in the lung and their slow dissolution in endosomes are
reported to be the primary reasons why inhalation of this form of
nickel is more toxic than inhalation of soluble nickel (2, 15).
However, there is still considerable risk of injury from prolonged
exposure to the soluble forms as well (27). The data in Fig. 6 are
consistent with these in vivo observations, because
transient exposure to soluble nickel sulfate stimulated neither a
hypoxic (Fig. 6A) nor an inflammatory response (Fig. 6B). However, cells in culture cannot clear toxicants in the
same manner as the intact lung, and kinetic differences between
different forms of nickel are often lost during continuous exposure
(15). The effects of losing this differential were seen as continuous exposure to soluble nickel increased IL-8 mRNA levels (Fig.
6B). These data contrast with previous reports that the
airway epithelial cells do not respond to nickel with increased
expression of IL-8 (14, 25). In these previous investigations, high
levels of nickel were used for only a 20-min exposure, which was
insufficient to elevate IL-8 protein levels or activate MAPK pathways.
The protracted time course of particulate nickel-stimulated IL-8
production observed in the present study contrasts with immediate IL-8
induction in response to cytokines, hypoxia (24), and many inhaled
toxicants, including cigarette smoke, asbestos (28), ozone (29),
particulate matter (14, 30), and viruses (22). IL-8 expression in
response to many stimuli is controlled mainly at the transcriptional
level (16). The lack of a nickel effect on message stability (Fig. 3)
and the stimulation of the IL-8 promoter constructs indicate that the
major action of nickel is transcription activation. However, the
results from the promoter analysis in Figs. 4 and 5 suggest that
induction by nickel diverges from the other inducers of IL-8 by acting
on elements outside of the cytokine-inducible portion of the promoter
that contains critical AP-1, NF-IL6, and NF- B elements (11, 16, 22,
24). The levels of Ni3S2 used do not stimulate
an immediate-early gene response in the BEAS-2B cells (4). Instead,
they cause protracted induction of both Fos and c-Jun (4). This
induction and associated AP-1 activity is necessary but not sufficient
for nickel-induced PAI-1 expression (4). Similarly, AP-1 appears to be
required for nickel induction of IL-8 (Figs. 5 and 8). However, the
AP-1 site at 126 to 120 bp, relative to the transcriptional start site, is insufficient to provide for full induction of the promoter (Figs. 4A and 5). This implies that the AP-1 site cooperates
with sites between 272 and 133 bp to respond to nickel. This region of the promoter has not been well studied but does contain putative GATA and C/EBP binding elements. Because both GATA and C/EBP families of binding proteins were implicated in regulating phenotypic change in
lung development and injury (31-34), these sites were the focus of
mutational analysis. The data in Fig. 5 indicate that both sites are
important for induction by nickel. However, it is also possible that
disrupting one of the sites influences the other because they are
adjacent. The data are also significant for the large increase in basal
transcription observed when the C/EBP site was mutated. TNF induction
was also increased by this mutation indicating that proteins that bound
to this site were repressive.
Ni3S2 mimics hypoxia-like responses in the
BEAS-2B cells, which result in stabilization of HIF-1 (Fig.
5A) and increased expression of PAI-1 and vascular epidermal
growth factor (3-5). Hypoxia induces IL-8 in several cell models
through poorly defined sites in the proximal promoter (24, 35). It is
unlikely that Ni3S2 induces IL-8 by mimicking
hypoxia, despite its chronic elevation of HIF-1 protein (Figs.
6A and 7A (3)). The data in Fig. 7 demonstrate
that blocking signals that increase HIF-1 levels or eliminating
HIF-1 synthesis had no effect on nickel-stimulated IL-8 expression.
The data in Fig. 4A indicate that the putative hypoxia-responsive element in the IL-8 promoter (24) lies in a region
that is not responsive to nickel. Thus, nickel stimulates divergent
signaling cascades to chronically induce inflammatory IL-8 and
profibrotic PAI-1 expression.
Despite the HIF independence of nickel-induced IL-8 expression, some of
the nickel-responsive signaling cascades that activate HIF or
HIF-responsive genes and IL-8 expression may be similar. Nickel-stimulated PAI-1 expression is attenuated but not eliminated by
inhibiting ERK and PI3K (3). As shown in the previous study and in Fig.
7A, both U0126 and R-59949 reduced the level of HIF-1 protein and transactivation in nickel-treated cells. A role for each of
these kinases in hypoxia- and non-hypoxia-induced HIF-1 gene
expression and transcriptional competence has been demonstrated (36-38). The data indicate that the divergence of IL-8 induction from
the hypoxia-like signaling must occur downstream of ERK and above
diacylglycerol kinase. Alternatively, both PAI-1 and IL-8 genes share
requirements for ERK and AP-1 for full induction. Divergence of
inducibility may come from the requirement for other trans-acting
factors that cooperate with AP-1. Induction of PAI-1 in nickel-exposed
cells requires HIF and AP-1 (3). Putative transcription factors binding
to the 272 to 133 region of the IL-8 promoter, such as C/EBP or
GATA family members, appear to be independent of HIF and diacylglycerol
kinase signaling. U0126 blocks ERK activation and
AP-1-dependent transcription (39, 40) and prevents
C/EBP-dependent gene expression (41). PI3K, in turn,
regulates multiple actions on C/EBP family members that result in
either increased or decreased transcriptional activation (42, 43).
However, as stated above, more studies are needed to identify the
proteins that bind to the 272 to 133 region and to define their
regulation in nickel-exposed cells. The lack of a role for p38 MAPK in
nickel-induced IL-8 expression is consistent with the lack of effects
of the p38 MAPK inhibitor on nickel-stimulated HIF-1 stability and
PAI-1 expression (3). This further distinguishes the actions of nickel
from hypoxia, which stimulates p38 MAPK to induce HIF-1 expression
and transcriptional activity (44, 45) and to phosphorylate and activate
xanthine oxidase (46).
In conclusion, the current studies indicate that particulate
Ni3S2 activates specific signaling cascades
following uptake by pulmonary epithelial cells. These activated
cascades stimulate parallel pathways for inducing transcription of both
inflammatory and profibrotic genes. The molecular switches for nickel
activation remain undefined, but must lie proximal to stimulation of
both hypoxia-like responses and stimulation of MAPK cascades. Further investigation will be needed to identify these molecular switches and
to further define the molecular program that supports chronic gene
activation by nickel. This chronic phenotypic change may play an
important role in the mechanisms driving increased incidence of
pulmonary diseases following environmental or occupational exposure to nickel.
 |
FOOTNOTES |
*
This work was supported by the Superfund Basic Research
Program at Dartmouth (Grant ES07373) and the facilities of the Norris Cotton Cancer Center.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pharmacology
and Toxicology, Dartmouth Medical School, 7650 Remsen, Hanover, NH
03755-3835. Tel.: 603-650-1673; Fax: 603-650-1129; E-mail: barchowsky@dartmouth.edu.
Published, JBC Papers in Press, April 26, 2002, DOI 10.1074/jbc.M202941200
 |
ABBREVIATIONS |
The abbreviations used are:
HIF, hypoxia-inducible factor;
PAI-1, plasminogen activator inhibitor-1;
IL-8, interleukin 8;
C/EBP, CAAT/enhancer-binding protein;
TNF, tumor
necrosis factor;
RT, reverse transcription;
EGFP, enhanced green
fluorescence protein;
PMA, phorbol 12-myristate 13-acetate;
PI3K, phosphatidylinositol 3-kinase;
ERK, extracellular signal-regulated
kinase;
MAPK, mitogen-activated protein kinase.
 |
REFERENCES |
| 1.
|
Laden, F.,
Neas, L. M.,
Dockery, D. W.,
and Schwartz, J.
(2000)
Environ. Health Perspect.
108,
941-947[Medline]
[Order article via Infotrieve]
|
| 2.
|
Kelleher, P.,
Pacheco, K.,
and Newman, L. S.
(2000)
Environ. Health Perspect.
108 Suppl. 4,
685-696
|
| 3.
|
Andrew, A. S.,
Klei, L. R.,
and Barchowsky, A.
(2001)
Am. J. Physiol.
281,
L607-L615[Abstract/Free Full Text]
|
| 4.
|
Andrew, A. S.,
Klei, L. R.,
and Barchowsky, A.
(2001)
Am. J. Physiol.
281,
L616-L623[Abstract/Free Full Text]
|
| 5.
|
Andrew, A. S.,
and Barchowsky, A.
(2000)
Toxicol. Appl. Pharmacol.
168,
50-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Keane, M. P.,
Arenberg, D. A.,
Lynch, J. P.,
Whyte, R. I.,
Iannettoni, M. D.,
Burdick, M. D.,
Wilke, C. A.,
Morris, S. B.,
Glass, M. C.,
DiGiovine, B.,
Kunkel, S. L.,
and Strieter, R. M.
(1997)
J. Immunol.
159,
1437-1443[Abstract]
|
| 7.
|
Ogushi, F.,
Tani, K.,
Maniwa, K.,
Ichikawa, W.,
Tada, H.,
Kawano, T.,
and Sone, S.
(1997)
J. Med. Invest
44,
53-58[Medline]
[Order article via Infotrieve]
|
| 8.
|
Ziegenhagen, M. W.,
Schrum, S.,
Zissel, G.,
Zipfel, P. F.,
Schlaak, M.,
and Muller-Quernheim, J.
(1998)
J. Invest. Med.
46,
223-231[Medline]
[Order article via Infotrieve]
|
| 9.
|
White, E. S.,
Strom, S. R.,
Wys, N. L.,
and Arenberg, D. A.
(2001)
J. Immunol.
166,
7549-7555[Abstract/Free Full Text]
|
| 10.
|
Belperio, J. A.,
Keane, M. P.,
Arenberg, D. A.,
Addison, C. L.,
Ehlert, J. E.,
Burdick, M. D.,
and Strieter, R. M.
(2000)
J Leukoc. Biol.
68,
1-8[Abstract/Free Full Text]
|
| 11.
|
Nakamura, H.,
Yoshimura, K.,
Jaffe, H. A.,
and Crystal, R. G.
(1991)
J. Biol. Chem.
266,
19611-19617[Abstract/Free Full Text]
|
| 12.
|
Schmalz, G.,
Schweikl, H.,
and Hiller, K. A.
(2000)
Eur. J. Oral Sci.
108,
442-448[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Terunuma, A.,
Aiba, S.,
and Tagami, H.
(2001)
J. Dermatol. Sci.
26,
85-93[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Carter, J. D.,
Ghio, A. J.,
Samet, J. M.,
and Devlin, R. B.
(1997)
Toxicol. Appl. Pharmacol.
146,
180-188[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Oller, A. R.,
Costa, M.,
and Oberdorster, G.
(1997)
Toxicol. Appl. Pharmacol.
143,
152-166[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Mukaida, N.,
Okamoto, S.,
Ishikawa, Y.,
and Matsushima, K.
(1994)
J. Leukoc. Biol.
56,
554-558[Abstract]
|
| 17.
|
Mukaida, N.,
Harada, A.,
Yasumoto, K.,
and Matsushima, K.
(1992)
Microbiol. Immunol.
36,
773-789[Medline]
[Order article via Infotrieve]
|
| 18.
|
Mukaida, N.,
Morita, M.,
Ishikawa, Y.,
Rice, N.,
Okamoto, S.,
Kasahara, T.,
and Matsushima, K.
(1994)
J. Biol. Chem.
269,
13289-13295[Abstract/Free Full Text]
|
| 19.
|
Wu, G. D.,
Lai, E. J.,
Huang, N.,
and Wen, X.
(1997)
J. Biol. Chem.
272,
2396-2403[Abstract/Free Full Text]
|
| 20.
|
Shumilla, J. A.,
Broderick, R. J.,
Wang, Y.,
and Barchowsky, A.
(1999)
J. Biol. Chem.
274,
36207-36212[Abstract/Free Full Text]
|
| 21.
|
Shumilla, J. A.,
and Barchowsky, A.
(1999)
Toxicol. Appl. Pharmacol.
158,
288-295[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Mori, N.,
Mukaida, N.,
Ballard, D. W.,
Matsushima, K.,
and Yamamoto, N.
(1998)
Cancer Res.
58,
3993-4000[Abstract/Free Full Text]
|
| 23.
|
Caniggia, I.,
Mostachfi, H.,
Winter, J.,
Gassmann, M.,
Lye, S. J.,
Kuliszewski, M.,
and Post, M.
(2000)
J. Clin. Invest.
105,
577-587[Medline]
[Order article via Infotrieve]
|
| 24.
|
Xu, L.,
Xie, K.,
Mukaida, N.,
Matsushima, K.,
and Fidler, I. J.
(1999)
Cancer Res.
59,
5822-5829[Abstract/Free Full Text]
|
| 25.
|
Samet, J. M.,
Graves, L. M.,
Quay, J.,
Dailey, L. A.,
Devlin, R. B.,
Ghio, A. J., Wu, W.,
Bromberg, P. A.,
and Reed, W.
(1998)
Am. J. Physiol.
275,
L551-L558
|
| 26.
|
English, A. M.,
and Wilcox, D. E.
(2001)
Met. Ions. Biol. Syst.
38,
313-350[Medline]
[Order article via Infotrieve]
|
| 27.
|
Haber, L. T.,
Erdreicht, L.,
Diamond, G. L.,
Maier, A. M.,
Ratney, R.,
Zhao, Q.,
and Dourson, M. L.
(2000)
Regul. Toxicol. Pharmacol.
31,
210-230[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Rosenthal, G. J.,
Germolec, D. R.,
Blazka, M. E.,
Corsini, E.,
Simeonova, P.,
Pollock, P.,
Kong, L. Y.,
Kwon, J.,
and Luster, M. I.
(1994)
J. Immunol.
153,
3237-3244[Abstract]
|
| 29.
|
Jaspers, I.,
Chen, L. C.,
and Flescher, E.
(1998)
J. Cell. Physiol.
177,
313-323[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Hetland, R. B.,
Refsnes, M.,
Myran, T.,
Johansen, B. V.,
Uthus, N.,
and Schwarze, P. E.
(2000)
J. Toxicol. Environ. Health
60,
47-65
|
| 31.
|
Molkentin, J. D.
(2000)
J. Biol. Chem.
275,
38949-38952[Free Full Text]
|
| 32.
|
Sugahara, K.,
Sadohara, T.,
Sugita, M.,
Iyama, K.,
and Takiguchi, M.
(1999)
Cell Tissue Res.
297,
261-270[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Choi, A. M.,
Sylvester, S.,
Otterbein, L.,
and Holbrook, N. J.
(1995)
Am. J. Respir. Cell Mol. Biol.
13,
74-82[Abstract]
|
| 34.
|
Alam, T., An, M. R.,
and Papaconstantinou, J.
(1992)
J. Biol. Chem.
267,
5021-5024[Abstract/Free Full Text]
|
| 35.
|
Karakurum, M.,
Shreeniwas, R.,
Chen, J.,
Pinsky, D.,
Yan, S.-D.,
Anderson, M.,
Sunouchi, K.,
Major, J.,
Hamilton, T.,
Kuwabara, K.,
Rot, A.,
Nowygrod, R.,
and Stern, D.
(1994)
J. Clin. Invest.
93,
1564-1570[Medline]
[Order article via Infotrieve]
|
| 36.
|
Aragones, J.,
Jones, D. R.,
Martin, S.,
San Juan, M. A.,
Alfranca, A.,
Vidal, F.,
Vara, A.,
Merida, I.,
and Landazuri, M. O.
(2001)
J. Biol. Chem.
276,
10548-10555[Abstract/Free Full Text]
|
| 37.
|
Berra, E.,
Milanini, J.,
Richard, D. E., Le,
Gall, M.,
Vinals, F.,
Gothie, E.,
Roux, D.,
Pages, G.,
and Pouyssegur, J.
(2000)
Biochem. Pharmacol.
60,
1171-1178[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Richard, D. E.,
Berra, E.,
Gothie, E.,
Roux, D.,
and Pouyssegur, J.
(1999)
J. Biol. Chem.
274,
32631-32637[Abstract/Free Full Text]
|
| 39.
|
Favata, M. F.,
Horiuchi, K. Y.,
Manos, E. J.,
Daulerio, A. J.,
Stradley, D. A.,
Feeser, W. S.,
Van Dyk, D. E.,
Pitts, W. J.,
Earl, R. A.,
Hobbs, F.,
Copeland, R. A.,
Magolda, R. L.,
Scherle, P. A.,
and Trzaskos, J. M.
(1998)
J. Biol. Chem.
273,
18623-18632[Abstract/Free Full Text]
|
| 40.
|
Yang, X.,
Chen, Y.,
and Gabuzda, D.
(1999)
J. Biol. Chem.
274,
27981-27988[Abstract/Free Full Text]
|
| 41.
|
Aubert, J.,
Dessolin, S.,
Belmonte, N., Li, M.,
McKenzie, F. R.,
Staccini, L.,
Villageois, P.,
Barhanin, B.,
Vernallis, A.,
Smith, A. G.,
Ailhaud, G.,
and Dani, C.
(1999)
J. Biol. Chem.
274,
24965-24972[Abstract/Free Full Text]
|
| 42.
|
Hemati, N.,
Ross, S. E.,
Erickson, R. L.,
Groblewski, G. E.,
and MacDougald, O. A.
(1997)
J. Biol. Chem.
272,
25913-25919[Abstract/Free Full Text]
|
| 43.
|
Entingh, A. J.,
Law, B. K.,
and Moses, H. L.
(2001)
Endocrinology
142,
221-228[Abstract/Free Full Text]
|
| 44.
|
Gorlach, A.,
Diebold, I.,
Schini-Kerth, V. B.,
Berchner-Pfannschmidt, U.,
Roth, U.,
Brandes, R. P.,
Kietzmann, T.,
and Busse, R.
(2001)
Circ. Res.
89,
47-54[Abstract/Free Full Text]
|
| 45.
|
Sodhi, A.,
Montaner, S.,
Patel, V.,
Zohar, M.,
Bais, C.,
Mesri, E. A.,
and Gutkind, J. S.
(2000)
Cancer Res.
60,
4873-4880[Abstract/Free Full Text]
|
| 46.
|
Kayyali, U. S.,
Donaldson, C.,
Huang, H.,
Abdelnour, R.,
and Hassoun, P. M.
(2001)
J. Biol. Chem.
276,
14359-14365[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. A. Nemec and A. Barchowsky
Signal Transducer and Activator of Transcription 1 (STAT1) is Essential for Chromium Silencing of Gene Induction in Human Airway Epithelial Cells
Toxicol. Sci.,
July 1, 2009;
110(1):
212 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ding, G. He, W. Gong, W. Wen, W. Sun, B. Ning, S. Huang, K. Wu, C. Huang, M. Wu, et al.
Effects of Nickel on Cyclin Expression, Cell Cycle Progression and Cell Proliferation in Human Pulmonary Cells
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2009;
18(6):
1720 - 1729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Andrew, R. A. Mason, V. Memoli, and E. J. Duell
Arsenic Activates EGFR Pathway Signaling in the Lung
Toxicol. Sci.,
June 1, 2009;
109(2):
350 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Kim, V. Rajagopal, C. Gonsalves, C. Johnson, and V. K. Kalra
A Novel Role of Hypoxia-Inducible Factor in Cobalt Chloride- and Hypoxia-Mediated Expression of IL-8 Chemokine in Human Endothelial Cells
J. Immunol.,
November 15, 2006;
177(10):
7211 - 7224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Kim, W. Reed, W. Wu, P. A. Bromberg, L. M. Graves, and J. M. Samet
Zn2+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human airway epithelial cells
Am J Physiol Lung Cell Mol Physiol,
May 1, 2006;
290(5):
L1028 - L1035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Ohyauchi, A Imatani, M Yonechi, N Asano, A Miura, K Iijima, T Koike, H Sekine, S Ohara, and T Shimosegawa
The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population
Gut,
March 1, 2005;
54(3):
330 - 335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-W. Ryoo, D.-U. Kim, M. Won, K.-S. Chung, Y.-J. Jang, G.-T. Oh, S.-K. Park, P.-J. Maeng, H.-S. Yoo, and K.-L. Hoe
Native LDL induces interleukin-8 expression via H2O2, p38 Kinase, and activator protein-1 in human aortic smooth muscle cells
Cardiovasc Res,
April 1, 2004;
62(1):
185 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. Pane, A. Haque, G. G. Goss, and C. M. Wood
The physiological consequences of exposure to chronic, sublethal waterborne nickel in rainbow trout (Oncorhynchus mykiss): exercise vs resting physiology
J. Exp. Biol.,
March 1, 2004;
207(7):
1249 - 1261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, G. Davidson, Y. Huang, B.-H. Jiang, X. Shi, M. Costa, and C. Huang
Nickel Compounds Act through Phosphatidylinositol-3-kinase/Akt-Dependent, p70S6k-Independent Pathway to Induce Hypoxia Inducible Factor Transactivation and Cap43 Expression in Mouse Epidermal Cl41 Cells
Cancer Res.,
January 1, 2004;
64(1):
94 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Iourgenko, W. Zhang, C. Mickanin, I. Daly, C. Jiang, J. M. Hexham, A. P. Orth, L. Miraglia, J. Meltzer, D. Garza, et al.
From the Cover: Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells
PNAS,
October 14, 2003;
100(21):
12147 - 12152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wang, P. P. Cleary, H. Xu, and J.-D. Li
Up-Regulation of Interleukin-8 by Novel Small Cytoplasmic Molecules of Nontypeable Haemophilus influenzae via p38 and Extracellular Signal-Regulated Kinase Pathways
Infect. Immun.,
October 1, 2003;
71(10):
5523 - 5530.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|